Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer

1999-05-17

British Journal of Cancer , Volume 80 - Issue 1-2 p. 286- 294

Additional Metadata
Keywords	Breast cancer, Cytosol, ELISA, Prognostic impact, Tissue-type plasminogen activator, tPA:PAI-1 complex
Persistent URL	doi.org/10.1038/sj.bjc.6690353, hdl.handle.net/1765/69628
Journal	British Journal of Cancer
Organisation	Department of Medical Oncology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	de Witte, J., Sweep, C. G. J., Klijn, J., Grebenschikov, N., Peters, H., Look, M., van Tienoven, D., Heuvel, J. J. T., Bolt-de Vries, J., Benraad, T. J.& Foekens, J. (1999). Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer. British Journal of Cancer, 80(1-2), 286–294.https://doi.org/10.1038/sj.bjc.6690353

Publication